Lung Cancer & COVID Infection

Trial Objectives

Researchers want to understand how the body of a person with active lung cancer responds to COVID-19, should they contract the virus. Volunteers do not need to be vaccinated or to have an active case of COVID to participate. Study participants will be required to provide a blood sample and their medical history.

Who Can Participate

Adults with an active diagnosis of lung cancer.

Age: 18+ Gender: Any

Estimated Time Commitment

Up to 24 months. In-person study visits occurring at enrollment and at these monthly intervals- 3, 6, 9, 12, 15, 18, 21 and 24 months.

Payment & Reimbursement

Payment: Not Provided

Travel Reimbursement: Not Available

Trial Contact

For more information, contact:

Daniell Plomondon
303-270-2041

Request More Information

Trial Location

National Jewish Main Campus, Denver, CO

Trial Sponsors

National Cancer Institute

Co-Investigators

Laurie L. Carr, MD
Ellen Volker, MD, MSPH

Request more Information

By completing this form, you agree to learn more about this study and see if you qualify.

First Name

Last Name

Email Address

Phone

I would also like to receive periodic emails with health information, news and clinical research updates from National Jewish Health

Yes